Hemab Therapeutics
NASDAQ: COAGIncorporated in Delaware · 5 known investors
Hemab is a biotechnology company developing targeted prophylactic therapies for people with serious bleeding and blood coagulation disorders that lack adequate treatment options. It focuses on shifting care toward prevention rather than management of bleeds.